Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism
- PMID: 20483771
- PMCID: PMC2887093
- DOI: 10.4049/jimmunol.0904054
Sepsis-induced apoptosis leads to active suppression of delayed-type hypersensitivity by CD8+ regulatory T cells through a TRAIL-dependent mechanism
Abstract
Patients who survive severe sepsis often display severely compromised immune function. One hallmark of such immune suppression in septic patients is an impaired delayed-type hypersensitivity (DTH) response, manifested by a loss of skin testing to recall Ags. Because sepsis induces significant apoptosis in lymphoid and myeloid cells, and apoptotic cells are themselves tolerogenic, we tested the hypothesis that suppression of DTH is mediated by tolerogenic properties of the apoptotic cells generated during sepsis. Mice subjected to cecal ligation and puncture demonstrated a loss of DTH for the 7 d following cecal ligation and puncture; however, the immune response returned to normal by day 10. Blocking sepsis-induced apoptosis via Bcl-2 overexpression or Bim deficiency prevented the loss of DTH. Importantly, injection of apoptotic cells into Bim-/- mice prevented an effective DTH response, thereby suggesting a causal link between apoptotic cells and immune suppression. Surprisingly, when TRAIL null mice were examined, we found that these animals had significant apoptosis but retained their DTH responses. Further studies revealed that apoptotic cells generated during sepsis induced a CD8+ regulatory T cell that suppressed DTH by TRAIL production. These results establish a link between apoptotic cells and immune suppression during sepsis and suggest TRAIL may be a viable therapeutic target for boosting the adaptive immune response following sepsis.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures





Similar articles
-
Immune unresponsiveness to secondary heterologous bacterial infection after sepsis induction is TRAIL dependent.J Immunol. 2011 Sep 1;187(5):2148-54. doi: 10.4049/jimmunol.1101180. Epub 2011 Jul 25. J Immunol. 2011. PMID: 21788440 Free PMC article.
-
Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.J Interferon Cytokine Res. 2015 Dec;35(12):969-80. doi: 10.1089/jir.2014.0235. Epub 2015 Aug 26. J Interferon Cytokine Res. 2015. PMID: 26309018 Free PMC article.
-
Bim siRNA decreases lymphocyte apoptosis and improves survival in sepsis.Shock. 2008 Aug;30(2):127-34. doi: 10.1097/shk.0b013e318162cf17. Shock. 2008. PMID: 18197142
-
Preferential control of induced regulatory T cell homeostasis via a Bim/Bcl-2 axis.Cell Death Dis. 2012 Feb 9;3(2):e270. doi: 10.1038/cddis.2012.9. Cell Death Dis. 2012. PMID: 22318539 Free PMC article.
-
T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression.Crit Rev Immunol. 2013;33(1):23-40. doi: 10.1615/critrevimmunol.2013006721. Crit Rev Immunol. 2013. PMID: 23510024 Free PMC article. Review.
Cited by
-
Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease.Exp Biol Med (Maywood). 2017 Jan;242(2):127-139. doi: 10.1177/1535370216669610. Epub 2016 Oct 4. Exp Biol Med (Maywood). 2017. PMID: 27633573 Free PMC article. Review.
-
Xenon Protects Against Septic Acute Kidney Injury via miR-21 Target Signaling Pathway.Crit Care Med. 2015 Jul;43(7):e250-9. doi: 10.1097/CCM.0000000000001001. Crit Care Med. 2015. PMID: 25844699 Free PMC article.
-
Part II: Minimum Quality Threshold in Preclinical Sepsis Studies (MQTiPSS) for Types of Infections and Organ Dysfunction Endpoints.Shock. 2019 Jan;51(1):23-32. doi: 10.1097/SHK.0000000000001242. Shock. 2019. PMID: 30106873 Free PMC article. Review.
-
Monitoring the immune response in sepsis: a rational approach to administration of immunoadjuvant therapies.Curr Opin Immunol. 2013 Aug;25(4):477-83. doi: 10.1016/j.coi.2013.05.006. Epub 2013 May 28. Curr Opin Immunol. 2013. PMID: 23725873 Free PMC article. Review.
-
Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.EMBO Mol Med. 2015 May;7(5):577-92. doi: 10.15252/emmm.201404653. EMBO Mol Med. 2015. PMID: 25766838 Free PMC article.
References
-
- Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303–1310. - PubMed
-
- Murphy SL. Deaths: final data for 1998. Natl Vital Stat Rep. 2000;48:1–105. - PubMed
-
- Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med. 2001;163:316–321. - PubMed
-
- Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock. 2001;16:83–96. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- GM44118/GM/NIGMS NIH HHS/United States
- R01 EY006765/EY/NEI NIH HHS/United States
- R56 AI077565/AI/NIAID NIH HHS/United States
- R01 GM055194/GM/NIGMS NIH HHS/United States
- GM55194/GM/NIGMS NIH HHS/United States
- R37 GM044118/GM/NIGMS NIH HHS/United States
- R01 GM044118/GM/NIGMS NIH HHS/United States
- F32 EY006765/EY/NEI NIH HHS/United States
- P30 EY002687/EY/NEI NIH HHS/United States
- R01 EY015570/EY/NEI NIH HHS/United States
- EY015570/EY/NEI NIH HHS/United States
- EY06765/EY/NEI NIH HHS/United States
- EY02687/EY/NEI NIH HHS/United States
- AI077565/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials